5 recruiting. 5 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Recruiting 5 |
| Phase 2 | 3 | Recruiting 3 |
Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE) Belimumab - Connective Tissue Diseases | Phase 3 | Recruiting | GlaxoSmithKline | 514 | 2024-12-12 | 2026-09-09 |
| RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis CABA-201 - Systemic Sclerosis, Scleroderma | Phase 2 / Phase 3 | Recruiting | Cabaletta Bio | 37 | 2024-07-02 | 2026-10-16 |
| Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate tab baricitinib 4 mg daily, tab methotrexate 25 mg weekly with folic acid 5 mg weekly - Diffuse Cutaneous Systemic Sclerosis | Phase 3 | Recruiting | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 24 | 2024-01-01 | 2025-04-20 |
| A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease Belimumab, Placebo - Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic | Phase 2 / Phase 3 | Recruiting | GlaxoSmithKline | 300 | 2023-09-13 | 2026-09-08 |
| Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk clopidogrel treatment, Placebo - Scleroderma, Systemic Sclerosis | Phase 2 / Phase 3 | Recruiting | University Hospital, Bordeaux | 90 | 2022-06-22 | 2026-07-07 |
Lung Diseases, Interstitial (3) · Scleroderma, Systemic (3) · Autoimmune Diseases (1) · Connective Tissue Diseases (1)
Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Connective Tissue Diseases (4) · Lung Diseases (3) · Respiratory Tract Diseases (3) · Scleroderma, Systemic (2) · Immune System Diseases (1)
belimumab (2) · Folic Acid (1) · Methotrexate (1) · baricitinib (1)
GlaxoSmithKline (2) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Cabaletta Bio (1) · University Hospital, Bordeaux (1)
France (3) · United States (3) · Argentina (2) · Australia (2) · China (2) · Greece (2) · Israel (2) · Japan (2) · South Korea (2) · Spain (2) · United Kingdom (2) · Bangladesh (1) · Belgium (1) · Brazil (1) · Denmark (1)
Dr MD. Fahad Hossain, MBBS, MD (1)
2023 (2)